A small molecule approach targeting tau aggregation was used to select and optimize compounds inhibiting tau self‐association in vitro that have translated in vivo in preventive studies in htau and P301L tau JNPL3 mouse models of tauopathy. This evidence concerns the gene MAPT and tauopathy.